Showing 911-920 of 8908 results for "".
Vitiligo Update: Pathogenesis, Therapies, and Integrative Approaches
https://practicaldermatology.com/issues/may-june-2025/vitiligo-update-pathogenesis-therapies-and-integrative-approaches/35920/Vitiligo is a chronic autoimmune condition characterized by depigmented white patches due to melanocyte destruction, attributed to genetic factors and environmental triggers.Differentiating GPP From Plaque Psoriasis for Targeted Therapy
https://practicaldermatology.com/issues/august-2025/differentiating-gpp-from-plaque-psoriasis-for-targeted-therapy/36700/While all types of psoriasis carry significant burdens of disease for patients, certain subtypes have more severe symptoms and require more urgency in diagnosis and treatment. Generalized pustular psoriasis (GPP) is one such subtype and may be considered a disease entity with a classification of itsPhio Pharmaceuticals Takes Aim at Skin Cancer
https://practicaldermatology.com/series/c-suite-chats/phio-pharmaceuticals-takes-aim-skin-cancer/24316/In the first episode of Practical Dermatology's C-Suite Chats, Robert Bitterman, CEO of Phio Pharmaceuticals, discusses the company's patented INTASYL technology. Learn more about this platform for creating and delivering uniquely modified siRNA compounds to treat cancer.FDA Approves Roflumilast for Seborrheic Dermatitis in Young Patients
https://practicaldermatology.com/topics/other-dermatitis/fda-approves-roflumilast-for-seborrheic-dermatitis-in-young-patients/20230/Patrick Burnett, MD, PhD, chief medical officer of Arcutis Biotherapeutics, talks with Practical Dermatology® about the first new treatment for seborrheic dermatitis in more than 20 years, their newly approved ZORYVE (roflumilast)Topical Foam, 0.3% for use in patients aged 9 years or older.Pediatric Derm: Sunscreen and Insect Repellent Safety
https://practicaldermatology.com/conferences/aad-summer-2021/pediatric-derm-sunscreen-and-insect-repellent-safety/19973/Parents of pediatric dermatology patients often have lots of questions when it comes to sunscreen safety, especially in light of recent headlines about recalls and absorption concerns. Mercedes Gonzalez, MD offers tips for answering these burning questions, including knowing how to discuss availableScientifically Speaking: Diagnosing and Treating Hair Loss, Part 1
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-diagnosing-and-treating-hair-loss-part-1/19954/Hair loss is distressing for many patients. The first step in management is to identify the cause of hair loss, modify contributing factors, and develop an effective treatment plan. Host Joel L. Cohen, MD discusses the challenges of managing hair loss with Marc Avram, MD, Cheryl Burgess, MD, and ReeCOVID-19 Impact: Decisions, decisions: Treating Psoriasis
https://practicaldermatology.com/topics/psoriasis/covid-19-impact-decisions-decisions-treating-psoriasis/19770/Physicians need to carefully weigh the risks and benefits of treating psoriasis patients with biologics or immunosuppressant agents during the COVID-19 pandemic, says Jashin J. Wu, MD. Many factors affect this decision including the severity of the psoriasis as well as any underlying medical conditiDigital v. Standard Photography: When and Why
https://practicaldermatology.com/topics/practice-management/digital-v-standard-photography-when-and-why/19762/For photo documentation for orienting pictures for biopsies, digital photos on iPads may be sufficient and allow for easy upload to a patient's chart, explains Todd Schlesinger, MD. But if you're looking for higher quality, cameras offer a better option. Dr. Schlesinger also offers tips for dermatolAdvances in Treating Pediatric Inflammatory Skin Diseases
https://practicaldermatology.com/topics/pediatric/advances-in-treating-pediatric-inflammatory-skin-diseases/19739/From new treatment guidelines to emerging biologic therapies for psoriasis in pediatric patients, Lawrence Eichenfield, MD says there’s new hope in successfully treating this patient population. He also discusses advances in treating pediatric atopic dermatitis.Advancing Treatment Parameters in Skin of Color with PicoWay
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advancing-treatment-parameters-in-skin-of-color-with-picoway/19623/Join William Kwan, MD for an overview of advanced treatment guidelines for addressing benign Pigmented Lesions with the PicoWay system. Learn how this picosecond laser has minimized risk relative to Q-switched lasers in the treatment of CALMs, lentigines, and more. New case studies from India and Ta